• Community News
  • Medical and Scientific News
  • Features
Canadian Hemophilia Society
  • Français
chsLogo
  • Community News
  • Medical and Scientific News
  • Features
Home / Articles posted by CHS/SCH (Page 7)
  • Access to Innovative and Curatives Therapies – NRBDO virtual conference

    By CHS/SCH on October 27, 2020

    NOVEMBER 5-7 Many innovative and curative therapies are coming to market for rare blood disorders, but will they be available to Canadian patients? What is...

  • COVID-19 updates

    By CHS/SCH on October 14, 2020

    Access the most updated information regarding COVID-19 and inherited bleeding disorders: www.hemophilia.ca/covid-19  

  • WFH Advisory: availability of desmopressin

    By CHS/SCH on October 6, 2020

    WFH Advisory: availability of desmopressin pending re-start of intranasal desmopressin manufacture 

  • Products in the pipeline

    By CHS/SCH on September 23, 2020

    It is an exciting time in the treatment of people with bleeding disorders with many coagulation products having been recently approved by Health Canada or...

  • Coagulation products

    By CHS/SCH on September 9, 2020

    www.hemophilia.ca/coagulation-products

Page 7 of 812345678
  • KEYWORDS

    ADVOCACY ageing A GLOBAL PERSPECTIVE AIDS CARRIERS CHS chapters Community COMPENSATION COVID-19 EMICIZUMAB GENE THERAPY HALF-LIFE FACTOR CONCENTRATES HEMLIBRA HEMOPHILIA A AND B HEPATITIS C HIV ICHIP INHIBITORS MYCBDR NURSING PHYSIOTHERAPY Platelet function disorders PROBE PROPHYLAXIS RARE BLEEDING DISORDERS RESEARCH SOCIAL WORK Tainted blood tragedy THE BLOOD FACTOR THE FEMALE FACTOR THERAPIES THE SAGE PAGE TWINNING VON WILLEBRAND DISEASE

Copyright © 2020 - Canadian Hemophilia Society. All rights reserved.

  • ARCHIVED HEMOPHILIA TODAY
  • ABOUT US